|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2200064075 |
|
最近更新日期: Date of Last Refreshed on: |
2022-09-26 09:14:32 |
|
注册时间: Date of Registration: |
2022-09-26 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
辅助生活空间对肌萎缩侧索硬化症患者及主要照顾者生活质量影响:单中心、前瞻性、单臂研究 |
|
Public title: |
Effect of assisted living space on the quality of life in ALS patients and their primary caregivers: a single-center, prospective, single-arm study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
辅助生活空间对肌萎缩侧索硬化症患者及主要照顾者生活质量影响的研究 |
|
Scientific title: |
Study on the impact of assisted living space on quality of life in ALS patients and primary caregivers |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
雷燕萍 |
研究负责人: |
查运红 |
|
Applicant: |
Lei Yanping |
Study leader: |
Zha Yunhong |
|
申请注册联系人电话: Applicant telephone: |
15897504101 |
研究负责人电话:
Study leader's |
13872662508 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
535895476@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
yha7808@ctgu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
湖北省宜昌市西陵区湖堤街4号 |
研究负责人通讯地址: |
湖北省宜昌市西陵区湖堤街4号 |
|
Applicant address: |
4 Hudi Street, Xiling District, Yichang, Hubei |
Study leader's address: |
4 Hudi Street, Xiling District, Yichang, Hubei |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
宜昌市第一人民医院 |
||
|
Applicant's institution: |
The First People's Hospital of Yichang |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
PJ-KY2022-18 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
宜昌市第一人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Yichang First People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-08-23 00:00:00 | ||
|
伦理委员会联系人: |
李佳卉 |
||
|
Contact Name of the ethic committee: |
Li Jiahui |
||
|
伦理委员会联系地址: |
湖北省宜昌市西陵区湖堤街4号 |
||
|
Contact Address of the ethic committee: |
4 Hudi Street, Xiling District, Yichang, Hubei |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
宜昌市第一人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First Hospital of Yichang |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
湖北省宜昌市西陵区湖堤街4号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
4 Hudi Street, Xiling District, Yichang, Hubei |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
self-raised |
||||||||||||||||||||||
|
研究疾病: |
肌萎缩侧索硬化症 |
||||||||||||||||||||||
|
Target disease: |
amyotrophic lateral sclerosis |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||
|
研究目的: |
研究目的: (一)主要目的:研究辅助生活空间对肌萎缩侧索硬化症患者生活质量影响。 (二)次要目的:探索辅助生活空间对ALS主要照顾者护理负担的影响。 |
||||||||||||||||||||||
|
Objectives of Study: |
Research purposes: (1) Main purpose: To study the effect of assisted living space on the quality of life of patients with amyotrophic lateral sclerosis. (2) Secondary objective: To explore the impact of assisted living spaces on the care burden of primary caregivers of ALS. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.患者纳入标准 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Patient inclusion criteria |
||||||||||||||||||||||
|
排除标准: |
1.患者排除标准: |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patient exclusion criteria: |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-10-01 00:00:00至 To 2023-02-28 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-10-01 00:00:00 至 To 2023-02-28 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本研究为单臂研究,不涉及随机方法。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
This study was a single-arm study and did not involve a randomized method. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
http://www.chictr.org.cn;中国临床试验注册中心 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
http://www.chictr.org.cn;Chinese Clinical Trial Registy |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
设计专门的纸质病例记录表和电子采集管理系统,首先将数据记录到纸质版病例记录表,然后及时上传到EDC中病例记录表电子采集和管理系统。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
We have designed a special paper case record form and an Electronic Data Capture, which first records the data into the paper version of the case record form, and then uploads it to EDC in time. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |